DTL
ABUS icon

Dynamic Technology Lab’s Arbutus Biopharma ABUS Stock Holding History

Dynamic Technology Lab’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,779
Closed -$124K – 833
2025
Q4 		$124K Buy
+25,779
New +$116K 0.03% 664
2023
Q1 		– Sell
-13,630
Closed -$32K – 1030
2022
Q4 		$32K Sell
13,630
-4,892
-26% -$11.7K ﹤0.01% 1033
2022
Q3 		$35K Buy
18,522
+1,194
+7% +$2.81K ﹤0.01% 1068
2022
Q2 		$47K Sell
17,328
-48,248
-74% -$123K 0.01% 1029
2022
Q1 		$195K Buy
+65,576
New +$201K 0.02% 948
2017
Q1 		– Sell
-40,017
Closed -$98K – 932
2016
Q4 		$98K Buy
+40,017
New +$116K 0.03% 811

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Dynamic Technology Lab's ABUS Position: Q1 2026 in Review

Dynamic Technology Lab sold out of Arbutus Biopharma (ABUS) in Q1 2026, closing a stake of 25,779 shares — an estimated $124K sold.

Dynamic Technology Lab first reported a position in ABUS in Q4 2016 and held it in 6 quarters. The position peaked at $195K in Q1 2022. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Dynamic Technology Lab reported no remaining Arbutus Biopharma position as of Q1 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 25,779 Arbutus Biopharma shares in Q1 2026, an estimated $124K.
  • Dynamic Technology Lab first reported a position in Arbutus Biopharma in Q4 2016 and held it in 6 quarters.
  • Dynamic Technology Lab's Arbutus Biopharma position peaked at $195K in Q1 2022.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.